Russian pharma market at tipping point says Quintiles
Quintiles says the Russian pharmaceutical market is at a tipping point and poised for significant expansion over the next decade.
Quintiles says the Russian pharmaceutical market is at a tipping point and poised for significant expansion over the next decade.
The EDQM will work to improve the quality of traditional Chinese medicines (TCM) sold in Europe under a memorandum of understanding (MoU) with SATCM.
The number of in-transit pharmaceutical robberies in the US has been sliced by almost half since last year, according to FreightWatch’s Biannual Cargo Theft Report.
The FDA is emphasising the key role both sponsors and CROs play in ensuring high quality clinical trials.
More-and-more US biopharm companies are moving from vials to prefilled syringes ahead of the upcoming flu season, according to BD.
Preclinical service revenue at Charles River slumped to its lowest level since 2005 in the second quarter, but margin gains helped earnings beat analysts’ estimates.
Software developer CliniWorks says data-mining is key to addressing trial sector’s “Achilles Heel,” patient recruitment.
Intelliject has received tentative US FDA approval for its e-cue ‘talking’ autoinjector, setting the device maker up for a potentially lucrative partnership with licensee French drug giant Sanofi.